Bertram Pitt

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Left Ventricular

Top Venues

Hypertension (Dallas, Tex. : 1979)

This page only lists publications with an associated author ORCID identifier.

Publications

Bertram Pitt, Javier Diez
Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart Disease. Hypertension (Dallas, Tex. : 1979) (2024)
Bertram Pitt, Gordon H Williams
Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators? Circulation 149 (6) (2024)
Faiez Zannad, Bertram Pitt
The Future of Clinical Trials. Circulation 149 (23) (2024)
Bertram Pitt, Gordon H Williams
Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators? Circulation 149 (6) (2024)
Sanjay Rajagopalan, Mirela A Dobre, Jean-Eudes Dazard, Armando Vergara-Martel, Kim Connelly, Michael E Farkouh, Juan Gaztanaga, Heather Conger, Ann Dever, Laleh Razavi-Nematollahi, Anas Fares, Gabriel Tensol Rodrigues Pereira, Jonnelle M Edwards, Mark J Cameron, Cheryl Cameron, Sadeer G Al-Kindi, Robert D Brook, Bertram Pitt, Matthew R Weir
Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial. Circulation (2024)
Bertram Pitt, Javier Diez
Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart Disease. Hypertension (Dallas, Tex. : 1979) 81 (7) (2024)
Sanjay Rajagopalan, Mirela A Dobre, Jean-Eudes Dazard, Armando Vergara-Martel, Kim Connelly, Michael E Farkouh, Juan Gaztanaga, Heather Conger, Ann Dever, Laleh Razavi-Nematollahi, Anas Fares, Gabriel Tensol Rodrigues Pereira, Jonnelle M Edwards, Mark J Cameron, Cheryl Cameron, Sadeer G Al-Kindi, Robert D Brook, Bertram Pitt, Matthew R Weir
Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial. Circulation 150 (9) (2024)
Bertram Pitt, Gordon H Williams
Aldosterone Synthase Inhibitors and Mineralocorticoid Receptor Antagonists: Competitors or Collaborators? Circulation 149 (6) (2024)
Jawad Haider Butt, John Joseph Valentine McMurray, Brian Lee Claggett, Pardeep S Jhund, Brendon L Neuen, Finnian R Mc Causland, Akshay S Desai, Carolyn Su Ping Lam, Bertram Pitt, Marc A Pfeffer, Milton Packer, Iris Beldhuis, Carolyn S P Lam, Faiez Zannad, Hiddo J Lambers Heerspink, Scott D Solomon, Muthiah Vaduganathan
Therapeutic Effects of Heart Failure Medical Therapies on Standardized Kidney Outcomes: Comprehensive Individual Participant-Level Analysis of 6 Randomized Clinical Trials. Circulation (2024)
Sanjay Rajagopalan, Mirela A Dobre, Jean-Eudes Dazard, Armando Vergara-Martel, Kim Connelly, Michael E Farkouh, Juan Gaztanaga, Heather Conger, Ann Dever, Laleh Razavi-Nematollahi, Anas Fares, Gabriel Tensol Rodrigues Pereira, Jonnelle M Edwards, Mark J Cameron, Cheryl Cameron, Sadeer G Al-Kindi, Robert D Brook, Bertram Pitt, Matthew R Weir
Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA Trial. Circulation 150 (9) (2024)
Bertram Pitt, Javier Diez
Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart Disease. Hypertension (Dallas, Tex. : 1979) 81 (7) (2024)
Bertram Pitt, Richard J Auchus
Chlorthalidone or Spironolactone for Patients With TRH and Advanced Chronic Kidney Disease? Hypertension (Dallas, Tex. : 1979) (2023)